GTS Securities’s Kronos Bio KRON Stock Holding History

GTS Securities’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,000	Closed	-$24.8K	–	1447
2025 Q1	$24.8K	Sell	30,000 -20,000	-40%	-$19.3K	﹤0.01%	1198
2024 Q4	$47.5K	Buy	+50,000	New	+$47.2K	﹤0.01%	1186

GTS Securities's KRON Position: Q2 2025 in Review

GTS Securities sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 30,000 shares — an estimated $24.8K sold.

GTS Securities first reported a position in KRON in Q4 2024 and held it in 2 quarters. The position peaked at $47.5K in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

GTS Securities reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
GTS Securities sold 30,000 Kronos Bio shares in Q2 2025, an estimated $24.8K.
GTS Securities first reported a position in Kronos Bio in Q4 2024 and held it in 2 quarters.
GTS Securities's Kronos Bio position peaked at $47.5K in Q4 2024.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.